Involvement of organic cation transporter 3 (Oct3/Slc22a3) in the bioavailability and pharmacokinetics of antidiabetic metformin in mice. Issue 5 (October 2016)
- Record Type:
- Journal Article
- Title:
- Involvement of organic cation transporter 3 (Oct3/Slc22a3) in the bioavailability and pharmacokinetics of antidiabetic metformin in mice. Issue 5 (October 2016)
- Main Title:
- Involvement of organic cation transporter 3 (Oct3/Slc22a3) in the bioavailability and pharmacokinetics of antidiabetic metformin in mice
- Authors:
- Shirasaka, Yoshiyuki
Lee, Nora
Zha, Weibin
Wagner, David
Wang, Joanne - Abstract:
- Abstract: Metformin is widely used for the treatment of type II diabetes mellitus. It was reported to be substrate of OCT3/Oct3, which is expressed in the brush boarder membrane of the enterocytes. However, the role of OCT3/Oct3 in the intestinal absorption process of metformin remains obscure. In the present study, we aimed to clarify the impact of Oct3 on the oral bioavailability and pharmacokinetics of metformin in mice, by means of in vivo pharmacokinetic study using wild-type (Oct3 +/+ ) and Oct3-knockout (Oct3 −/− ) mice. When metformin (8.0 mg/kg) was intravenously administered to male Oct3 +/+ and Oct3 −/− mice, AUC0–∞ of metformin was evaluated to be 659 ± 133 μg h/mL and 734 ± 213 μg h/mL, respectively. In the case of orally administered metformin (15 mg/kg), AUC0–∞ was 578 ± 158 μg h/mL and 449 ± 101 μg h/mL in Oct3 +/+ and Oct3 −/− mice, respectively. Based on these pharmacokinetic parameters, absolute bioavailability ( F ) of metformin in Oct3 +/+ mice was evaluated as 46.8%, and it was significantly decreased to 32.6% in Oct3 −/− mice. Taking into account the fact that metformin undergoes negligible metabolism, these results imply that intestinal absorption of metformin is mediated at least in part by Oct3 in mice. Graphical abstract:
- Is Part Of:
- Drug metabolism and pharmacokinetics. Volume 31:Issue 5(2016)
- Journal:
- Drug metabolism and pharmacokinetics
- Issue:
- Volume 31:Issue 5(2016)
- Issue Display:
- Volume 31, Issue 5 (2016)
- Year:
- 2016
- Volume:
- 31
- Issue:
- 5
- Issue Sort Value:
- 2016-0031-0005-0000
- Page Start:
- 385
- Page End:
- 388
- Publication Date:
- 2016-10
- Subjects:
- Metformin -- OCT3 -- Transporter -- Intestinal absorption -- Bioavailability -- Mouse
AUC area under the plasma concentration–time curve -- CL clearance -- Cmax maximum concentration -- OCT/Oct organic cation transporter -- SLC solute carrier -- tmax time to maximum concentration
Drugs -- Metabolism -- Periodicals
Pharmacokinetics -- Periodicals
615.7 - Journal URLs:
- http://www.sciencedirect.com/science/journal/13474367 ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/j.dmpk.2016.04.005 ↗
- Languages:
- English
- ISSNs:
- 1347-4367
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.328000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2298.xml